華仁藥業(300110.SZ):計提2020年度資產減值準備及核銷資產
格隆匯 3 月 21日丨華仁藥業(300110.SZ)公佈,公司於2021年3月18日召開第七屆董事會第三次會議和第七屆監事會第三次會議,審議通過了《關於計提2020年度資產減值準備及核銷資產的議案》。
根據《深圳證券交易所創業板上市公司規範運作指引》、《創業板信息披露業務備忘錄第10號—定期報吿披露相關事項》《企業會計準則》《關於進一步提高上市公司財務信息披露質量的通知》及公司會計政策等相關規定的要求,公司及下屬子公司對2020年末各類存貨、應收款項、長期股權投資項目進行了全面清查,對各類存貨的可變現淨值,應收款項回收的可能性以及長期股權投資回收的可能性進行了充分的評估和分析,認為上述資產中部分資產存在減值跡象,因此公司對公司及子公司應收款項、存貨、長期股權投資計提資產減值準備共計5511.62萬元。
公司報吿期內計提資產減值準備5835.588萬元、轉回或轉銷資產323.96萬元,核銷資產45.235萬元,上述事項共計減少2020年度利潤總額5511.62萬元。此次計提資產減值準備及資產核銷已經中興華會計師事務所審計確認。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.